Acceptance and Commitment Therapy for Cancer-Related Psychological Symptoms
(ACTION Trial)
Trial Summary
What is the purpose of this trial?
This research study is being done to develop an intervention for psychological symptoms that patients diagnosed with cancer may experience. Psychological symptoms may include thoughts, feelings, emotions, and memories The names of the study intervention and research activities involved in this study are/is: * Acceptance \& Commitment Therapy (ACT) for Cancer (involving 6 sessions with a licensed clinical psychologist) * Questionnaires * Post-study interview Consistent with the NIH Stage Model for Behavioral Intervention Development, the investigators have adapted an existing, empirically-validated intervention, Acceptance and Commitment Therapy (ACT), to address substance use disorder risk during cancer care. The core components of ACT are particularly well-suited to address the psychological processes underlying opioid misuse in individuals treated for cancer pain. The overarching aim is to assess the feasibility and acceptability of the intervention by conducting a randomized pilot trial of the revised intervention ("ACTION") for cancer patients on opioid therapy, and at risk for SUD.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, it mentions that participants should currently be on opioid therapy, so you may need to continue with that specific medication.
What data supports the effectiveness of the treatment Acceptance and Commitment Therapy (ACT) for cancer-related psychological symptoms?
Is Acceptance and Commitment Therapy (ACT) safe for cancer patients?
How is Acceptance and Commitment Therapy (ACT) different from other treatments for cancer-related psychological symptoms?
Acceptance and Commitment Therapy (ACT) is unique because it focuses on increasing psychological flexibility, helping patients adapt better to their condition by accepting their thoughts and feelings rather than trying to change them. This approach is part of the third wave of cognitive behavioral therapy and is particularly promising for addressing the psychological distress associated with cancer.14589
Research Team
Miryam Yusufov, PhD
Principal Investigator
Dana-Farber Cancer Institute
Eligibility Criteria
This trial is for adults over 18 with any type of cancer, expected to live at least 6 more months, and who are on opioid therapy with a risk for substance use disorder. They should be able to do daily activities with little to no help and must understand English well enough for psychotherapy.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Acceptance & Commitment Therapy (ACT) for Cancer, involving 6 sessions with a licensed clinical psychologist
Follow-up
Participants are monitored for safety and effectiveness after treatment, including a post-study interview
Treatment Details
Interventions
- Acceptance & Commitment Therapy (ACT) for Cancer
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dana-Farber Cancer Institute
Lead Sponsor
National Cancer Institute (NCI)
Collaborator